Collaborations Pharmaceuticals (United States)
- World rank, all time
- #22,371 of 42,892
- Rank in United States
- #4,828 of 8,685
- Research works
- 146 ▲ 106% vs 2013–17
- Citations
- 4.1k 28.2 per fractional work
- Top-10% rate
- 23.1% record average 16.5%
- Open access
- 69% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 12.7×
- Veterinary 4.9×
- Decision Sciences 4.5×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Immunology and Microbiology 2.4×
- Medicine 1.9×
- Computer Science 1.7×
- Chemistry 1.0×
- Neuroscience 1.0×
- Materials Science 0.9×
- Economics, Econometrics and Finance 0.8×
- Environmental Science 0.7×
- Arts and Humanities 0.6×
- Agricultural and Biological Sciences 0.6×
- Business, Management and Accounting 0.5×
- Mathematics 0.5×
- Social Sciences 0.2×
- Psychology 0.2×
- Engineering 0.1×
Who are the top researchers at Collaborations Pharmaceuticals (United States)?
Ranked on the composite score, Sean Ekins lead among researchers whose main affiliation is Collaborations Pharmaceuticals (United States).
- 1 Sean Ekins United States · #528,774 worldwide 209 citations · 94 works
Which keywords describe research at Collaborations Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Pharmacokinetics, Machine Learning, Medicinal Chemistry, Molecular Docking, Virtual Screening, Pandemic, Vaccine and ACE2 Receptor.
- Toxicology
- Bibliometric Analysis
- Nuclear Receptors
- Ethical Considerations
- Materials Informatics
- Pharmacogenetics
- Cytochrome P450
- Physician-Scientist
- Alzheimer's Disease
- Drug Development
- Genomics
- Genetic Variation
- Big Data
- Immune Response
- Viral Transmission
- SARS-CoV-2
- Vaccine
- Pandemic
- Molecular Docking
- Pharmacokinetics
- Machine Learning
- Medicinal Chemistry
- Virtual Screening
- Epidemiology
- ACE2 Receptor
- Immunity
- Coronavirus
- spike protein
- Capacity Building
- Drug Resistance
- Data Mining
- Interdisciplinary Research
- Medical Research
- Precision Medicine
- Molecular Dynamics
- High-Throughput
- Pharmacology
- Neurodegenerative Diseases
- Pesticides
- Parkinson's Disease
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Machine Learning9▲ 4.9×6 topics
- Pharmacokinetics8▲ 50×3 topics
- Medicinal Chemistry6▲ 36×2 topics
- Molecular Docking6▲ 76×1 topic
- Virtual Screening6▲ 103×1 topic
- Pandemic5▲ 8.7×4 topics
- Epidemiology5▲ 2.1×17 topics
- Vaccine4▲ 18×6 topics
- ACE2 Receptor4▲ 27×2 topics
- SARS-CoV-24▲ 21×2 topics
- Immunity3▲ 14×4 topics
- Viral Transmission3▲ 37×2 topics
- Coronavirus3▲ 23×1 topic
- Immune Response3▲ 8.5×7 topics
- spike protein3▲ 46×1 topic
- Big Data3▲ 5.2×4 topics
- Capacity Building2▲ 71×3 topics
- Genetic Variation2▲ 19×3 topics
- Drug Resistance2▲ 14×5 topics
- Genomics2▲ 13×3 topics
- Data Mining2▲ 5.0×2 topics
- Drug Development2▲ 44×2 topics
- Interdisciplinary Research2▲ 43×2 topics
- Alzheimer's Disease2▲ 13×2 topics
- Medical Research2▲ 120×1 topic
- Physician-Scientist2▲ 120×1 topic
- Precision Medicine2▲ 7.4×3 topics
- Cytochrome P4502▲ 98×1 topic
- Molecular Dynamics2▲ 20×2 topics
- Pharmacogenetics2▲ 165×1 topic
- High-Throughput2▲ 61×1 topic
- Materials Informatics2▲ 61×1 topic
- Pharmacology2▲ 12×3 topics
- Ethical Considerations2▲ 7.9×3 topics
- Neurodegenerative Diseases2▲ 17×3 topics
- Nuclear Receptors2▲ 30×4 topics
- Pesticides2▲ 40×3 topics
- Bibliometric Analysis2▲ 47×1 topic
- Parkinson's Disease2▲ 11×3 topics
- Toxicology2▲ 16×2 topics
Which research topics does Collaborations Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Computational Drug Discovery Methods, SARS-CoV-2 and COVID-19 Research, Health and Medical Research Impacts and Pharmacogenetics and Drug Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Computational Drug Discovery Methods Computational Theory and Mathematics 6 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 3 works
- 3 Health and Medical Research Impacts Public Health, Environmental and Occupational Health 2 works
- 4 Pharmacogenetics and Drug Metabolism Pharmacology 2 works
- 5 Machine Learning in Materials Science Materials Chemistry 2 works
- 6 scientometrics and bibliometrics research Statistics, Probability and Uncertainty 2 works
- 7 Cholinesterase and Neurodegenerative Diseases Pharmacology 1 works
- 8 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 1 works
- 9 Lysosomal Storage Disorders Research Physiology 1 works
- 10 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Collaborations Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 106% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Raleigh
- North Carolina State University
- PRA Health Sciences
- North Carolina Division of Public Health
- North Carolina Exploring Cultural Heritage Online
- NC Department of Health and Human Services
- Gad Consulting Services (United States)
- University of North Carolina System
- Meredith College
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.